Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice

DNA and Cell Biology

Volumn 16, Issue 12, 1997, Pages 1439-1448

  Grange, Marie Pierre ^a   Armand, Marie Astrid ^a   Audoly, Gilles ^a   Thollot, Delphine ^a   Desgranges, Claude ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; REX PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; HELPER CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNIZATION; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031411005     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.1997.16.1439     Document Type: Article

References (16)

1. AGADJANYAN, M.G., WANG, B., UGEN, K.E., VILLAFANA, T., MERVA, M., PETRUSHINA, I., WILLIAMS, W.V., and WEINER, B. (1994). DNA inoculation with an HTLV-I envelope DNA construct elicits immune responses in rabbits. In Vaccines 94 (Cold Spring Harbor Press), 47-53.
2. ARP, J., FORD, C.M., PALKER, T.J., KING, E.E., and DEKABAN, G.A. (1993). Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system. J. Gen. Virol. 74, 211-222.
3. ARTHOS, S.L.J., MONTEFIORI, D.C., YASUTOMI, Y., MANSON, K., MUSTAFA, F., JOHNSON, E., SANTORO, J.C., WISSINK, J., MULLINS, J.L., HAYNES, J.R., LETVIN, N.L., WYAND, M., and ROBINSON, H.L. (1996). Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70, 3978-3991.
4. BABA, E., NAKAMURA, M., TANAKA, Y., KUROKI, M., ITOYAMA, Y., NAKANO, S., and NIHO, Y. (1993). Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type I (HTLV-I) identified by human monoclonal antibodies. J. Immunol. 151, 1013-1024.
5. BENJOUAD, A., GLUCKMAN, J.C., ROCHAT, H., MONTAGNIER, L., and BAHRAOUI, E. (1992). Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp120. J. Virol. 66, 2473-2483.
6. BLATTNER, W. (1990). Epidemiology of HTLV-I and associated diseases. In Human Retrovirology Blattner, W.A. (Ed.) Raven, New York, 251-263.
7. CARDOSO, A.I., BLIXENKRONE-MOLLER, M., FAYOLLE, J., LIU, M., BUCKLAND, R. and WILD, T.F. (1996). Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology 225, 293-299.
8. CLAPHAM, P., NAGY, K., and WEISS, R. (1984). Pseudotypes of human T-cell leukemia virus type I and II: Neutralization by patient's sera. Proc. Natl. Acad. Sci. USA 81, 2886-2889.
9. DAVIS, H.L., MICHEL, M.L., and WHALEN, R.G. (1993). DNA-immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Molec. Genetics 3, 1847-1851.
10. DELAMARRE, L., ROSENBERG, A.R., PIQUE, C., PHAM, D., and DOKHELAR, M.C. (1997). A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J. Virol. 71, 259-266.
11. DESGRANGES, C., SOUCHE, S., VERNANT, J.C., SMADJA, D., VAHLNE, A., and HORAL, P. (1994). Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res. Hum. Retroviruses 10, 163-173.
12. FRANCHINI, G., TARTAGLIA, J., MARKAM, P., BENSON, J., FULLEN, J., WILLS, M., DEKABAN, A.J.G., PAOLETTI, E., and GALLO, R.C. (1995). Highly attenuated HTLV type I env poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits. AIDS Res. Hum. Retroviruses 11, 307-313.
13. GESSAIN, A., BARIN, F., VERNANT, J.C., GOUT, O., MAURS, L., CALENDER, A., and DE THE, G. (1985). Antibodies to human T lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet ii, 407-410.
14. HAIGWOOD, N.L., NARA, P.L., BROOKS, E., VAN NEST, G.A., OTT, G., HIGGINS, K.W., DUNLOP, N., SCANDELLA, C.J., EICHBEIRG, J.W., and STEIMER, K.S. (1992). Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J. Virol. 66, 172-182.
15. HAKODA, E., MOCHIDA, H., TANAKA, Y., MORISHITA, N., SAWADA, T., SHIDA, H., HOSHINO, H., and MIYOSHI, I. (1995). Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int. J. Cancer 60, 567-570.
16. HIDAKA, M., INOUE, J., YOSHIDA, M., and SEIKI, M. (1988). Posttranscriptional regulator (Rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7, 519-523.